Professor Joel Lexchin: Some Canadian drugs are overpriced before they are patented
Professor Joel Lexchin: Some Canadian drugs are overpriced before they are patented
Canada needs a new system for controlling drug prices that does not depend on whether or not a drug has received a patent, according to an article by York Professor Dr. Joel Lexchin. Drug prices in Canada can be unregulated for years, a period during which companies may overprice the drugs and market them, says […]